Clinical Trials of Adenoviruses in Brain Tumors: A Review of Ad-p53 and Oncolytic Adenoviruses

被引：0
作者：
Giacomo G. Vecil
Frederick F. Lang
机构：
[1] The University of Texas M.D. Anderson Cancer Center,Department of Neurosurgery
来源：
Journal of Neuro-Oncology | 2003年 / 65卷
关键词：
adenovirus; Delta-24; gene therapy; glioblastoma; ONYX-015; p53;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Adenoviruses have been critical in the development of the molecular approaches to brain tumors. They have been engineered to function as vectors for delivering therapeutic genes in gene therapy strategies, and as direct cytotoxic agents in oncolytic viral therapies. This review outlines the uses of adenoviruses in brain tumor therapy by examining clinical trials of adenovirus-mediated p53 gene therapy and by reviewing the application of two conditionally replicative adenoviruses (CRAds) ONYX-015 and Delta 24 in brain tumors. The potential clinical use of CRAds that deliver trangenes, particularly p53, is also discussed.
引用
收藏
页码：237 / 246
页数：9
相关论文
共 667 条
  • [1] Walker AE(1985)Epidemiology of brain tumors: the national survey of intracranial neoplasms Neurology 35 219-226
  • [2] Robins M(2000)Update on adenovirus and its vectors J Gen Virol 81 2573-2604
  • [3] Weinfeld FD(2001)Cancer gene therapy by adenovirus-mediated gene transfer Curr Gene Ther 1 101-122
  • [4] Russell WC(2002)The presence of the adenovirus E3 region improves the oncolytic potency of conditionally replicative adenoviruses Clin Cancer Res 8 3348-3359
  • [5] Wu Q(2002)Leukemia case triggers tighter gene-therapy controls Natl Med 8 1189-296
  • [6] Moyana T(1998)Gene therapy of cancer Immunol Today 19 294-287
  • [7] Xiang J(2001)Delivery of cell cycle genes to block astrocytoma growth J Neuro-Oncol 51 277-141
  • [8] Suzuki K(2001)Cancer gene therapy: fringe or cutting edge? Natl Rev Cancer 1 130-59
  • [9] Alemany R(2002)Adenoviral gene therapy Oncologis 7 46-203
  • [10] Yamamoto M(2000)Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors Mol Ther 1 195-2205
12345678910